# Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Esophageal Cancer

> **NCT00021320** · PHASE2 · COMPLETED · sponsor: **Fox Chase Cancer Center** · enrollment: 21 (actual)

## Conditions studied

- Esophageal Cancer

## Interventions

- **DRUG:** cisplatin
- **DRUG:** fluorouracil
- **DRUG:** paclitaxel
- **PROCEDURE:** conventional surgery
- **PROCEDURE:** neoadjuvant therapy
- **RADIATION:** radiation therapy

## Key facts

- **NCT ID:** NCT00021320
- **Lead sponsor:** Fox Chase Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-05
- **Primary completion:** 2004-01
- **Final completion:** 2009-04
- **Target enrollment:** 21 (ACTUAL)
- **Last updated:** 2014-05-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00021320

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00021320, "Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Esophageal Cancer". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00021320. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*